Search Results 261-270 of 17399 for Bronchodilators

1. Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer - Mayo Clinic

   ... bronchodilator that is < 80% predicted or personal best [if known]). Current symptomatic congestive heart failure (New York Heart Association > class II) ...

2. COPD - Doctors and departments - Mayo Clinic

   This ongoing lung disease limits airflow into and out of the lungs. This results in trouble breathing, cough with mucus and wheezing.

3. The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial. - Mayo Clinic

   Those using antihypertensive or antiarrhythmic agents; Those with significant cardiopulmonary comorbidities (namely history of arrhythmia, coronary artery ...

4. Comparison of Respiratory Pathogen Detection in Upper Versus Lower Respiratory Tract Samples using the Biofire Filmarray Respiratory Panel - Mayo Clinic

   The purpose of this study is to compare the performance of the FilmArray Respiratory Panel in nasopharyngeal (NP) swabs and bronchoalveolar lavage (BAL) fluid ...

5. Bronchoscopy - Doctors & Departments - Mayo Clinic

   A doctor inserts a small, flexible tube through your mouth or nose into your lungs to look at your air passages and find the cause of a lung problem.

6. Pulmonary Medicine Clinical Trials - Medical Professionals

   There is no standard of care therapy for patients with granulomatous-lymphocytic interstitial lung disease (GLILD) seen in common variable immunodeficiency ( ...

7. Dupilumab Treatment on Sinonasal Respiratory Symptoms and Sense of Smell in Ethnically Diverse Patients with Chronic Rhinosinusitis and Nasal Polyps - Mayo Clinic

   ... bronchodilator forced expiratory volume in 1 second (FEV) and quality-of-life measures in patients with uncontrolled, moderate-to-severe asthma, with ...

8. Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2) - Mayo Clinic

   About this study. This is a multicenter, randomized, double-blind, parallel group, chronic-dosing (24 weeks), placebo-controlled study to assess the ...

9. Digital Platform for Remote Monitoring of COPD After Bronchoscopic Lung Volume Reduction - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

10. Pulmonary Medicine Clinical Trials - Medical Professionals

    Find pulmonary clinical trials at your nearest Mayo Clinic location.